Muscular dystrophy md refers to a group of more than 30 genetic diseases that cause muscle degeneration, progressive weakness and chronic or permanent shortening of tendons and muscles. Oculopharyngeal muscular dystrophy opmd is a rare cause for lateonset dysphagia. Like many of you, we were shocked and scared by this diagnosis. Epidemiology and inheritance of oculophyaryngeal muscular dystrophy in israel. It can also be associated with proximal and distal extremity. Oculopharyngeal muscular dystrophy opmd is a rare form of muscular dystrophy that causes progressive muscle weakness predominantly in the eye oculo and throat pharyngeal muscles. Dystrophin provides the connection between a large multimeric complex of glycoproteins in the muscle cell membrane.
Treatment focuses on symptom management and can include steroids, physical therapy, breathing support devices and surgery. Oculopharyngeal muscular dystrophy opmd is an autosomal dominant disorder characterized by slowly progressive bilateral ptosis, dysphagia, extraocular muscle weakness, and proximal limb weakness. More detailed information about the inheritance of opmd can be viewed on our web site by clicking here. An individual who may be at risk for having inherited a mutation for opmd may benefit from learning the type of opmd that is present in the family, if possible. The condition has been reported in over 30 countries. Jun 14, 2016 oculopharyngeal muscular dystrophy opmd is a genetic disorder characterized by slowly progressing muscle disease myopathy affecting the muscles of the upper eyelids and the throat. Myotonic dystrophy modified from o brien and kunkel, children s hospital, boston.
One affected member also had total external ophthalmoplegia and weakness of the limbgirdle muscles. Statistics of oculopharyngeal muscular dystrophy 8 people with oculopharyngeal muscular dystrophy have taken the sf36 survey. Opmd a rare form of muscular dystrophy in which muscles that control the eyelids and swallowing are primarily affected. Opmd is among the few triplet repeat diseases polyalanine polya expansion diseases. Disruption of gene expression or chromosomal organization. Duchenne muscular dystrophy dmd is a genetic condition that affects the muscles, leading to muscle wasting that gets worse over time. Can oculopharyngeal muscular dystrophy be prevented. Oculopharyngeal muscular dystrophy opmd is classically an autosomal dominant condition most often found in people with frenchcanadian ancestry where it is estimated to affect 1 in 1,000 individuals, although there are some rarer recessively inherited mutations as well.
The muscular dystrophy campaign mdc has booklets written for boys with dmd. Duchenne muscular dystrophy this document is a translation of the french recommendations drafted by dr. Clinical features opmd typically presents with ptosis, dysarthria, and dysphagia. Due to a lack of clinical suspicion and the rarity of the disease, the diagnosis is often missed. Duchenne muscular dystrophy genes and disease ncbi. The oculopharyngeal muscular dystrophy opmd is a late onset hereditary muscle disease which is characterised by the selective affection of the pharyngeal muscles resulting in swallowing disorders, and by a ptosis from the dysfunction of the levator palpebral superiors muscles. Boston, massachusetts in 1879, hutchinson described external ophthalmoplegia in which blepharoptosis was associated with paralysis of other extraocular muscles. In 1986, mdasupported scientists identified the gene that, when defective, causes duchenne muscular dystrophy. Oculopharyngeal muscular dystrophy as a rare differential. Muscular dystrophy md is a group of more than 30 inherited diseases. The genetic basis of the condition has been identified recently as a stable trinucleotide repeat expansion in exon 1 of the polya binding protein 2 gene pabp2, in which gcg 6 is the normal repeat. Oculopharyngeal muscular dystrophy opmd is a rare myopathy that is characterized by ocular and pharyngeal muscle involvement, leading to ptosis and dysphagia. Treatment of dysphagia in oculopharyngeal muscular dystrophy.
Pdf oculopharyngeal muscular dystrophy an underdiagnosed. Paquin, ryan fischer, carol mansfield, brennan mange, katherine beaverson, annie ganot, amy strong martin, carl morris, colin rensch, valeria ricotti, leo j. Because theyre less common, they can be difficult to diagnose, and many questions remain to be answered about their symptoms and progression. Priorities when deciding on participation in earlyphase gene therapy trials for duchenne muscular dystrophy. Duchenne muscular dystrophy genes and disease ncbi bookshelf. Pabpn1 gene therapy for oculopharyngeal muscular dystrophy. Neurodevelopmental, behavioral, and emotional symptoms common. Opmd normally follows an autosomal dominant inheritance. Opmd is a genetic condition that is most commonly inherited in an autosomal dominant manner a. Oculopharyngeal muscular dystrophy opmd is a rare form of muscular dystrophy with symptoms generally starting when an individual is 40 to 50 years old. This form of muscular dystrophy appears in men and women in their 40s, 50s, and 60s.
Oculopharyngeal muscular dystrophy genetic and rare. Oculopharyngeal muscular dystrophy opmd is a lateonset autosomal dominant muscular dystrophy which presents typically after the age of 50 with progressive eyelid drooping and an increasing. Muscular dystrophy is a broad label used to describe a group of genetic disorders that cause muscle degeneration and weak ness. Nine members of 3 generations were known to be affected. Find your symptoms soulmates from now on you can add your symptoms in diseasemaps and find your symptoms soulmates. Dec 16, 2008 the oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11. Muscular dystrophy information page national institute of. Oculopharyngeal muscular dystrophy opmd is a genetic disease that is characterized by muscle wasting. Oculopharyngeal muscular dystrophy opmd the term muscular dystrophy is used to cover a wide range of conditions which have in common progressive muscle weakness and wasting owing to an inherited genetic defect mutation.
Decline in lung volume with duchenne muscular dystrophy is. Mean of oculopharyngeal muscular dystrophy is 1164 points 32 %. Oculopharyngeal muscular dystrophy opmd barbeaus disease. Certain genes are involved that protect the fibers of the muscles from damage. Opmd is a rare, slowly progressive myopathy that is characterized by weakness of the eyelids ocular and throat pharyngeal muscles. Oculopharyngeal muscular dystrophy opmd what is oculopharyngeal muscular dystrophy opmd. Duchenne muscular dystrophy genetic and rare diseases nih.
The different types can vary in whom they affect, which muscles they affect, and what the symptoms are. Muscular dystrophy uk has created conditionspecific alert cards for different musclewasting conditions. Treatment of dysphagia in oculopharyngeal muscular. This has led to better classification of this group of heterogeneous neuromuscular disorders based on clinical features. Oculopharyngeal muscular dystrophy opmd is an autosomal dominant disorder of late onset that commonly presents with ptosis and dysphagia. Abstract introduction we studied neurodevelopmental and behavioralemotional symptoms in patients with duchenne muscular dystrophy. It was first termed opmd by victor and colleagues in 1962 victor et al. Muscular dystrophy, oculopharyngeal definition of muscular. Links to pubmed are also available for selected references.
Oculopharyngeal muscular dystrophy genetics home reference. Affected individuals usually first experience weakness of the muscles in both eyelids that. The most common inheritance of opmd is autosomal dominant, which means only one copy of the mutated gene needs to be. Explaining muscular dystrophy to your friends and family will play a vital role in your acceptance of your current situation. Symptoms people with opmd do not usually develop symptoms until after the age of 40, with an average age of onset of around 50. Oculopharyngeal muscular dystrophy opmd is a genetic disorder characterized by slowly progressing muscle disease myopathy affecting the muscles of the upper eyelids and the throat. Congenital, distal, emerydreifuss and oculopharyngeal. Additionally, opmd can be associated with proximal near the body midline and distal limb muscle weakness. Some things it is useful to know about duchenne muscular. The different types can vary in whom they affect, which muscles they affect, and what the.
Pdf oculopharyngeal muscular dystrophy associated with. Guideline on the clinical investigation of medicinal products for the. As its name implies, muscles that control the eyelids oculo and throat pharyngeal are typically the first affected in opmd patients. A family affected with oculopharygeal muscular dystrophy opmd is reported. Total score ranges from 0 to 3,600 being 0 the worst and 3,600 the best. Recent distrofoa on oculopharyngeal muscular dystrophy in quebec. Cardiac involvement in patients with muscular dystrophies. Explaining muscular dystrophy to your family and friends. Dystrophin is usually absent in patients with duchenne muscular dystrophy, but is reduced in amount or abnormal in size in people with becker muscular dystrophy. Oculopharyngeal muscular dystrophy in focus dear readers opmd is a form of muscular dystrophy in which symptoms usually first appear between the 30s and 60s, and primarily involve the muscles of the upper eyelids and the swallowing muscles. Cmd is the second most common cause of muscular dystrophy in japan, but is rare in other countries. Duchenne and becker muscular dystrophy dmd and bmd, respectively are xlinked disorders affecting the synthesis of dystrophin, a large sarcolemmal protein that is absent in dmd 11 and reduced in amount or abnormal in size in bmd patients 12. Muscular dystrophies sathasivam s the walton centre nhs foundation trust, lower lane, liverpool l9 7lj, united kingdom abstract huge strides have been made in the last two decades in our understanding of muscular dystrophies. Symptoms generally appear when the person is 40 to 60 years old.
Congenital muscular dystrophy nord national organization. Some forms of md are seen in infancy or childhood, while others may not appear until. Duchenne muscular dystrophy dmd is one of a group of muscular dystrophies characterized by the enlargement of muscles. Opmd is characterized by slowly progressive muscle disease myopathy affecting the muscles of the upper eyelids and the throat. If one of these genes is defective, muscular dystrophy occurs.
Oculopharyngeal muscular dystrophy is a genetic condition characterized by muscle weakness that begins in adulthood, typically after age 40. Since then, researchers have forged ahead to isolate and characterize genes involved in almost all the neuromuscular disorders in mdas program, including those responsible for oculopharyngeal muscular dystrophy opmd. What is the most common form of muscular dystrophy in. The term oculopharyngeal refers to the eyes oculo and a part of the throat called the pharynx pharyngeal. Respiratory involvement contributes significantly to morbidity and mortality in patients with neuromuscular disorders. Muscular dystrophy information page national institute. Herein we describe a rare case of an autosomal recessive inheritance of opmd. These discoveries have enabled scientists to understand. Definitiondiagnosis criteria oculopharyngeal muscular dystrophy opmd is an autosomal dominant form of lateonset slowly progressive myopathy. Full text full text is available as a scanned copy of the original print version. It can be autosomal dominant neuromuscular disease or autosomal recessive. The muscular dystrophies md are a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement. Oculopharyngeal muscular dystrophy brain oxford academic. Pdf oculopharyngeal muscular dystrophy associated with dementia.
It progresses slowly, causing weakness in the eye and face muscles, which. We report the medical odyssey of a 57year old male caucasian patient. Muscular dystrophies sathasivam s the walton centre nhs foundation trust, lower lane, liverpool l9 7lj, united kingdom. Symptoms soulmates are people with similar symptoms to you.
Oculopharyngeal muscular dystrophy as a rare cause of. A rare form of muscular dystrophy in which muscles that control the eyelids and swallowing are primarily affected. Oculopharyngeal muscular dystrophy opmd is inherited in either an autosomal dominant or an autosomal recessive manner. Oculopharyngeal muscular dystrophy is a genetic disease distinguished by the onset of ptosis, dysphagia, and weakness of voluntary skeletal muscles in elderly individuals. Dmd is one of the most prevalent types of muscular dystrophy and is characterized by rapid progression of muscle degeneration that occurs early in life. As these muscles weaken, patients have difficulty keeping their eyes open and find that. An 80yearold male presented with progressive dysphagia, frequent aspiration and change of voice getting inarticulate and hoarse. The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11. Onset is typically during adulthood, most often between 40 and 60 years of age. Get a printable copy pdf file of the complete article 672k, or click on a page image below to browse page by page. There is huge variation in severity between the different conditions.
Oculopharyngeal muscular dystrophy opmd is a rare form of muscular dystrophy that causes progressive muscle weakness predominantly in the eye oculo and throat pharyngeal muscles patients usually appear healthy before the onset of disease symptoms, typically between ages 40 to 60. Familial late onset oculopharyngeal muscular dystrophy. The proband presented for evaluation of secretory otitis media with effusion, as a result of tubal dysfunction. Oct 16, 2008 the oculopharyngeal muscular dystrophy opmd is a late onset hereditary muscle disease which is characterised by the selective affection of the pharyngeal muscles resulting in swallowing disorders, and by a ptosis from the dysfunction of the levator palpebral superiors muscles. Cmd with secondary merosin deficiency type 1 mdc1b is characterized by diminished muscle tone hypotonia, muscle weakness of the muscles closer to the center of the body proximal muscles, generalized overgrowth of some muscles hypertrophy, rigidity of the spine, and contractures especially.
Duchenne muscular dystrophy is characterised by progressive symmetrical muscular weakness that affects proximal muscles more than distal. Oculopharyngeal muscular dystrophy opmd is a rare genetic muscle disorder with onset during adulthood most often between 40 and 60 years of age. Oculopharyngeal muscular dystrophy opmd is an autosomal dominant muscle disorder, usually of late onset. Patients usually appear healthy before the onset of disease symptoms, typically between ages 40 to 60. Choking, food regurgitation, and possibly lifethreatening aspiration pneumonia are rare but important complications. It is a late adult onset autosomal dominant form of muscular dystrophy that constitutes as a rare diagnosis for any place outside of canada and first case in southern germany. Jun 15, 2016 oculopharyngeal muscular dystrophy opmd affects males and females in equal numbers. Oculopharyngeal muscular dystrophy opmd is an autosomal dominant, lateonset muscle disorder characterized by ptosis, swallowing difficulties, proximal limb weakness and. Affected individuals may develop drooping of the eyelids ptosis. Affected individuals usually first experience weakness of the muscles in both eyelids that causes droopy eyelids ptosis.
Food and drug administration fda granted accelerated approval to golodirsen injection to treat duchenne muscular dystrophy dmd patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. All are xlinked and affect mainly malesan estimated 1 in 3500 boys worldwide. The ninds is a member of the muscular dystrophy coordinating committee mdcc. Ptosis and dysphagia beginning in the patients late 40s or early 50s are characteristic symptoms. Diagnosis and management of duchenne muscular dystrophy, part 3. The duchenne muscular dystrophy gene product is localized in the sarcolemma of human skeletal muscle. Variability and trends in corticosteroid use by male united states participants with duchenne muscular dystrophy in the duchenne registry. The most common inheritance of opmd is autosomal dominant, which means only one copy of the mutated gene needs to be present in each cell.
780 276 61 1462 1654 1017 348 1467 1318 289 1467 807 1203 1376 1473 482 1063 941 148 948 869 340 901 526 1134 1184 575 1454 627 424 237 1240 391 164 532